Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR600 host gene (MIR600HG) is a long non-coding RNA (lncRNA) gene located on chromosome 9 and is also referenced as FLJ22161, GL012, C9orf45, and NCRNA00287[2][3]. It is not protein-coding and its transcript acts as the precursor or host transcript for the microRNA miR-600. While its exact biological functions remain undercharacterized, associations with diseases such as pancreatic ductal adenocarcinoma, glioma susceptibility, and Alzheimer's disease have been reported[2]. There is currently no evidence to suggest that MIR600HG itself serves as a therapeutic target, nor are there known direct drug interactions or established biomarker or safety data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR600 host gene (non-protein coding) (MIR600HG).